Covaxin gets DCGI nod for 6-12 age group, Corbevax for 5-12-year-olds
- 2 years ago
The Drugs Controller General of India (DCGI) Tuesday granted restricted emergency use authorisation (EUA) to Bharat Biotech’s Covaxin for children between the age group of 6-12 years. Apart from this, the drug regulator approved two more vaccines. Corbevax has been granted EUA for the age group 5-12 years and Zydus Cadila’s two-dose Covid-19 vaccine has been approved for adults.